• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非诺贝特负载的聚乙烯吡咯烷酮静电纺丝微纤维片的制备与表征

Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets.

作者信息

Sipos Emese, Csatári Tamás, Kazsoki Adrienn, Gergely Attila, Bitay Enikő, Szabó Zoltán-István, Zelkó Romána

机构信息

Department of Drugs Industry and Pharmaceutical Management, University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Gh. Marinescu 38, 540139 Targu Mures, Romania.

University Pharmacy Department of Pharmacy Administration, Semmelweis University, H-1092 Hőgyes Endre utca 7-9, 1085 Budapest, Hungary.

出版信息

Pharmaceutics. 2020 Jun 30;12(7):612. doi: 10.3390/pharmaceutics12070612.

DOI:10.3390/pharmaceutics12070612
PMID:32629988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407498/
Abstract

Fenofibrate-loaded electrospun microfibrous sheets were prepared in an attempt to enhance the dissolution of the poorly soluble antihyperlipidemic agent and to improve its bioavailability. Physicochemical changes that appeared during the electrospinning process were monitored using a wide array of solid-state characterization techniques, including attenuated total reflectance Fourier-transformed infrared spectroscopy and positron annihilation lifetime spectroscopy, while fiber morphology was monitored via scanning electron microscopy. Dissolution studies carried out both in 0.025 M sodium dodecyl sulfate and in water revealed an immediate release of the active agent, with an approximately 40-fold release rate enhancement in water when compared to the micronized active agent. The dramatic increase in dissolution was attributed partially to the amorphous form of the originally crystalline active agent and the rapid disintegration of the electrospun microfibrous sheet due to its high surface area and porosity. The obtained results could pave the way for a formulation of the frequently used antihyperlipidemic agent with increased bioavailability.

摘要

制备了载有非诺贝特的电纺微纤维片,旨在提高难溶性抗高血脂药物的溶出度并改善其生物利用度。使用包括衰减全反射傅里叶变换红外光谱和正电子湮没寿命光谱在内的一系列固态表征技术监测电纺过程中出现的物理化学变化,同时通过扫描电子显微镜监测纤维形态。在0.025 M十二烷基硫酸钠和水中进行的溶出度研究表明,活性剂能立即释放,与微粉化活性剂相比,在水中的释放速率提高了约40倍。溶出度的显著增加部分归因于原本结晶的活性剂的无定形形式以及电纺微纤维片因其高表面积和孔隙率而迅速崩解。所得结果可为制备具有更高生物利用度的常用抗高血脂药物制剂铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/f84da8625396/pharmaceutics-12-00612-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/c2cb2a75f59c/pharmaceutics-12-00612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/319687702aaf/pharmaceutics-12-00612-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/dedee8f0e6f9/pharmaceutics-12-00612-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/340d9a2dd992/pharmaceutics-12-00612-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/d7cae07156f2/pharmaceutics-12-00612-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/f84da8625396/pharmaceutics-12-00612-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/c2cb2a75f59c/pharmaceutics-12-00612-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/319687702aaf/pharmaceutics-12-00612-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/dedee8f0e6f9/pharmaceutics-12-00612-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/340d9a2dd992/pharmaceutics-12-00612-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/d7cae07156f2/pharmaceutics-12-00612-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cba/7407498/f84da8625396/pharmaceutics-12-00612-g006.jpg

相似文献

1
Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets.非诺贝特负载的聚乙烯吡咯烷酮静电纺丝微纤维片的制备与表征
Pharmaceutics. 2020 Jun 30;12(7):612. doi: 10.3390/pharmaceutics12070612.
2
Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride.用于增强盐酸奈必洛尔口服溶出度的纳米纤维片材的制备与表征
J Pharm Biomed Anal. 2016 Sep 10;129:224-228. doi: 10.1016/j.jpba.2016.07.004. Epub 2016 Jul 5.
3
Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.使用聚合物纳米颗粒系统提高非诺贝特的口服生物利用度:理化特性及体内研究
Int J Nanomedicine. 2015 Mar 5;10:1819-30. doi: 10.2147/IJN.S78895. eCollection 2015.
4
Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.用于提高难溶性非诺贝特的水溶性和口服生物利用度的新型电喷雾纳米球。
Int J Nanomedicine. 2016 Jan 12;11:213-21. doi: 10.2147/IJN.S97496. eCollection 2016.
5
Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.卡维地洛在旋转纺丝微纤维中的晶态-非晶态转变跟踪及其制成口腔崩解片以增强体外溶出度的制剂研究。
J Pharm Biomed Anal. 2015 Nov 10;115:359-67. doi: 10.1016/j.jpba.2015.07.042. Epub 2015 Jul 30.
6
Microstructural Distinction of Electrospun Nanofibrous Drug Delivery Systems Formulated with Different Excipients.不同辅料构建的静电纺丝纳米纤维药物传递系统的微观结构区别。
Mol Pharm. 2018 Sep 4;15(9):4214-4225. doi: 10.1021/acs.molpharmaceut.8b00646. Epub 2018 Aug 1.
7
Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.一种具有介孔结构的氧化锡载体的研发,用于提高非诺贝特的溶出速率和口服相对生物利用度。
Drug Des Devel Ther. 2018 Jul 10;12:2129-2138. doi: 10.2147/DDDT.S166989. eCollection 2018.
8
Orthogonal experimental preparation of Sanguis Draconis- Polyvinylpyrrolidone microfibers by electrospinning.静电纺丝法制备正交设计血竭-聚乙烯吡咯烷酮微纤维
J Biomater Sci Polym Ed. 2019 Mar;30(4):308-321. doi: 10.1080/09205063.2019.1570432. Epub 2019 Feb 9.
9
Influence of Aqueous Solubility-Enhancing Excipients on the Microstructural Characteristics of Furosemide-Loaded Electrospun Nanofibers.水溶性增强辅料对载速尿电纺纳米纤维微观结构特征的影响
Pharmaceutics. 2020 Apr 23;12(4):385. doi: 10.3390/pharmaceutics12040385.
10
Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.薄膜冷冻法制备和传递改良非诺贝特无定形固体分散体。
Eur J Pharm Biopharm. 2012 Nov;82(3):534-44. doi: 10.1016/j.ejpb.2012.06.016. Epub 2012 Sep 5.

引用本文的文献

1
Preparation and Characterization of Fenofibrate-Loaded Fibers Based on 2-Hydroxylpropyl-β-Cyclodextrin.基于2-羟丙基-β-环糊精的非诺贝特载药纤维的制备与表征
Polymers (Basel). 2025 Apr 11;17(8):1037. doi: 10.3390/polym17081037.
2
One-Step Preparation of Fiber-Based Chlorzoxazone Solid Dispersion by Centrifugal Spinning.通过离心纺丝一步法制备纤维基氯唑沙宗固体分散体
Polymers (Basel). 2023 Dec 29;16(1):123. doi: 10.3390/polym16010123.
3
Positron Annihilation Lifetime Spectroscopy as a Special Technique for the Solid-State Characterization of Pharmaceutical Excipients, Drug Delivery Systems, and Medical Devices-A Systematic Review.

本文引用的文献

1
Towards controlling the crystallisation behaviour of fenofibrate melt: triggers of crystallisation and polymorphic transformation.关于控制非诺贝特熔体的结晶行为:结晶触发因素及多晶型转变
RSC Adv. 2018 Apr 10;8(24):13513-13525. doi: 10.1039/c8ra01182f. eCollection 2018 Apr 9.
2
Formulation and Characterization of Aceclofenac-Loaded Nanofiber Based Orally Dissolving Webs.载醋氯芬酸纳米纤维口服速溶片的制备与表征
Pharmaceutics. 2019 Aug 17;11(8):417. doi: 10.3390/pharmaceutics11080417.
3
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications.
正电子湮没寿命谱作为药物辅料、药物递送系统和医疗器械固态表征的特殊技术——系统综述
Pharmaceuticals (Basel). 2023 Feb 7;16(2):252. doi: 10.3390/ph16020252.
静电纺丝和静电纺纳米纤维:方法、材料与应用。
Chem Rev. 2019 Apr 24;119(8):5298-5415. doi: 10.1021/acs.chemrev.8b00593. Epub 2019 Mar 27.
4
Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.静电纺丝技术制备的难溶性药物无定形固体分散体:综述
J Control Release. 2018 Dec 28;292:91-110. doi: 10.1016/j.jconrel.2018.08.016. Epub 2018 Aug 14.
5
Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy.用宽带介电谱研究非晶态药物非诺贝特的分子动力学。
J Pharm Anal. 2016 Jun;6(3):165-170. doi: 10.1016/j.jpha.2014.09.003. Epub 2014 Sep 16.
6
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations.当前可用非诺贝特和非诺贝酸制剂综述。
Cardiol Res. 2013 Apr;4(2):47-55. doi: 10.4021/cr270w. Epub 2013 May 9.
7
Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride.用于增强盐酸奈必洛尔口服溶出度的纳米纤维片材的制备与表征
J Pharm Biomed Anal. 2016 Sep 10;129:224-228. doi: 10.1016/j.jpba.2016.07.004. Epub 2016 Jul 5.
8
Support Tools in Formulation Development for Poorly Soluble Drugs.难溶性药物制剂开发中的支持工具
J Pharm Sci. 2016 Aug;105(8):2260-9. doi: 10.1016/j.xphs.2016.05.024. Epub 2016 Jun 29.
9
Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.使用超临界二氧化碳将非诺贝特负载于介孔二氧化硅上。
Int J Pharm. 2016 Feb 29;499(1-2):1-9. doi: 10.1016/j.ijpharm.2015.12.049. Epub 2015 Dec 28.
10
Incorporating small molecules or biologics into nanofibers for optimized drug release: A review.将小分子或生物制剂纳入纳米纤维以实现优化的药物释放:综述
Int J Pharm. 2015 Oct 15;494(1):516-30. doi: 10.1016/j.ijpharm.2015.08.054. Epub 2015 Aug 22.